—
ATLASense Biomed is redefining remote health surveillance with its enhanced REPHAEL Platform, a comprehensive system that detects critical early warning signs in both hospital and home settings, empowering healthcare teams to prevent patient deterioration before it escalates. This breakthrough underscores ATLASense’s commitment to setting new standards in patient care worldwide.
Recognized as an innovator in medical technology, ATLASense earned accolades at the 2020 Henry Ford Health System Global Monitoring Competition, highlighting the REPHAEL Platform's effectiveness and real-world impact on healthcare.
REPHAEL: A Leap Forward in Predictive Health Monitoring
The REPHAEL Platform represents a milestone in remote monitoring, designed as a continuous, AI-powered health surveillance system that supports personalized patient care. Uniquely positioned as the only system offering 1-3 day predictive alerts for critical conditions like Acute Respiratory Distress Syndrome (ARDS), respiratory insufficiency, and early sepsis, REPHAEL equips healthcare teams with life-saving insights that improve outcomes and reduce healthcare costs.
"ATLASense is transforming patient care by offering predictive tools that address health crises before they intensify," said a spokesperson for ATLASense. "REPHAEL combines advanced AI and multi-sensor technology to deliver unparalleled early-warning capabilities, empowering clinicians with timely, actionable insights."
With patented technology integrating multi-sensor arrays and sophisticated algorithms, REPHAEL can analyze subtle physiological changes, such as diaphragm electrical activity, to detect imminent health issues with remarkable precision. These insights support critical clinical decisions, saving lives and elevating patient care.
Addressing the Growing Need for Proactive Health Solutions
As healthcare systems face increased demands, effective patient monitoring is essential. The REPHAEL Platform addresses this need by enhancing the capacity of medical teams, enabling better resource allocation and patient management. This proactive approach not only streamlines care but also alleviates the strain on healthcare resources.
Looking forward, ATLASense is expanding REPHAEL’s capabilities to address a broader range of health complications, setting a new standard in preventive medical care and improving outcomes for patients worldwide.
About Us: ATLASense Biomed is a trailblazer in remote health monitoring, recognized for its innovative solutions and led by Israel's top healthcare and MedTech experts. Its REPHAEL Platform, a patented AI-based system, stands out globally for its predictive monitoring capabilities for conditions like ARDS and sepsis. Committed to improving patient outcomes and reducing healthcare costs, ATLASense leverages advanced technology to enhance healthcare efficiency on a global scale.
Contact Info:
Name: Tal Or
Email: Send Email
Organization: ATLASense Biomed
Address: 1 Ezer Weizman St., Hod Hasharon Israel, 4502552
Phone: +972-54-770-6688
Website: https://atlasensebiomed.com/
Release ID: 89145892
Google
RSS